Use of renin–angiotensin–aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study

The Lancet
May 30, 2020 Volume 395 Number 10238 p1669-1738, e98-e100
https://www.thelancet.com/journals/lancet/issue/current

 

Use of renin–angiotensin–aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study
Francisco J de Abajo, et al on behalf of the MED-ACE2-COVID19 study group